Therefore, we hypothesized that aberrant upregulation of cyclin A2 in gastric cancer cells may elicit synthetic lethal vulnerability to PLK1 inhibition through failed cell cycle progression, particularly at the M phase. This evidence concerns the gene CCNA2 and gastric cancer.